Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

A toddler with unusual hypothyroidism symptoms improved with levothyroxine treatment.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

People with Alopecia Areata often have thyroid problems like Hashimoto thyroiditis and hypothyroidism.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Chick embryo extract helps rat hair follicle stem cells become more like neurons.

TRPV1 is involved in pain, various body functions, and diseases, but targeting it for treatment is challenging.

Two sisters had a rare hair condition without other usual symptoms.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Hormones and genes affect hair growth and male baldness.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Hypothyroidism patients with hair loss typically have thinning hair, smaller hair follicles, and normal hair shedding.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Combining medication and minimally invasive techniques can effectively manage Marine-Lenhart syndrome.

Mutations in the Vitamin D receptor gene can cause hair loss similar to mutations in the Hairless gene.

AT-Grow, a natural product, might help with a common type of hair loss by reducing DHT levels.

A mutation in the iRhom2 gene causes hairless mice due to abnormal hair follicle development.